Working… Menu

Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis (Saturn-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04475432
Recruitment Status : Completed
First Posted : July 17, 2020
Last Update Posted : July 7, 2021
Information provided by (Responsible Party):
Tarsus Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 4, 2021
Actual Study Completion Date : May 4, 2021